August 20, 2014 — Three out of four people would want to know what kind of neurological disorder they had, even if there was no cure, according to new global research from GE Healthcare. The “Value of Knowing” global survey of 10,000 adults across 10 countries explored perspectives on incurable neurological disorders including Alzheimer’s (AD) and Parkinson’s (PD) disease.

iCAD Inc. announced the signing of a definitive agreement to acquire DermEbx, an electronic brachytherapy services and technology provider, and Radion Inc., a cloud-based oncology collaboration software solution.

August 18, 2014 — Additive manufacturing (3-D printing) company Oxford Performance Materials (OPM) was named the "Best Global Company for 3-D Healthcare Innovation" by The New Economy Awards. The New Economy Awards, presented by The New Economy magazine, identify and celebrate innovative companies that are breaking new ground in the areas of technology, energy, business and strategy.

August 18, 2014 — The Association for Medical Imaging Management (AHRA) announced the seventh year of its Putting Patients First Program. Putting Patients First grants enable healthcare facilities to fund programs, training or seminars aimed at improving patient care and safety and customizing treatment in CT (computed tomography), MR (magnetic resonance), ultrasound, X-ray and vascular imaging. The grants are funded by an unrestricted educational grant from Toshiba America Medical Systems.

Guided Therapeutics Inc. announced that U.S. Patent and Trademark Office granted a new patent with 22 claims that support the technology behind the LuViva Advanced Cervical Scan.

Spellman High Voltage Ltd. announced that it has received a certificate of qualification from Underwriters Laboratories Inc. (UL) stating that the company has been assessed and found eligible to participate in UL's Client Test Data Program (CTDP).

August 14, 2014 — Oncologists at UC San Diego Moores Cancer Center are the first in San Diego to meld magnetic resonance imaging (MRI) technology with a traditional ultrasound prostate exam to create a 3-D map of the prostate that allows physicians to view growths that were previously undetectable.